Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L P Balant

Showing results (1-10 of 68) with videos related to

Pageof 7
Sort By:
Therapie|August 1, 1988
[Nephrotoxicity. Pharmacokinetic aspects]L P Balant
Bollettino Chimico Farmaceutico|May 1, 1993
Regulatory aspects of modified release dosage forms: clinical studiesL P Balant
Clinical Therapeutics|January 1, 1984
Pharmacokinetics in the 1980sL P Balant
Therapie|July 1, 1987
[Renal insufficiency and drug metabolism]L P Balant
Lancet (London, England)|August 19, 1978
Low-dose oral propranololL P Balant, J Fabre
Comprehensive Therapy|October 1, 1978
Clinical significance of proteinuriaL P Balant, J Fabre
Journal of Chromatography. B, Biomedical Applications|March 29, 1996
Investigation of xenobiotic metabolism by CYP2D6 and CYP2C19: importance of enantioselective analytical methodsA Marzo, L P Balant
Arzneimittel-Forschung|February 1, 1995
Bioequivalence. An updated reappraisal addressed to applications of interchangeable multi-source pharmaceutical productsA Marzo, L P Balant
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|November 1, 1990
Physiological pharmacokinetic modellingL P Balant, M Gex-Fabry
Bollettino Chimico Farmaceutico|June 1, 1993
Pharmacokinetics/pharmacodynamics during phase II and III studies: population kinetics and the kinetic screenL P Balant, M Gex-Fabry
Pageof 7

Showing results (1-10 of 68) with videos related to

Sort By:
Pageof 7
Therapie|August 1, 1988
[Nephrotoxicity. Pharmacokinetic aspects]L P Balant
Bollettino Chimico Farmaceutico|May 1, 1993
Regulatory aspects of modified release dosage forms: clinical studiesL P Balant
Clinical Therapeutics|January 1, 1984
Pharmacokinetics in the 1980sL P Balant
Therapie|July 1, 1987
[Renal insufficiency and drug metabolism]L P Balant
Lancet (London, England)|August 19, 1978
Low-dose oral propranololL P Balant, J Fabre
Comprehensive Therapy|October 1, 1978
Clinical significance of proteinuriaL P Balant, J Fabre
Journal of Chromatography. B, Biomedical Applications|March 29, 1996
Investigation of xenobiotic metabolism by CYP2D6 and CYP2C19: importance of enantioselective analytical methodsA Marzo, L P Balant
Arzneimittel-Forschung|February 1, 1995
Bioequivalence. An updated reappraisal addressed to applications of interchangeable multi-source pharmaceutical productsA Marzo, L P Balant
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|November 1, 1990
Physiological pharmacokinetic modellingL P Balant, M Gex-Fabry
Bollettino Chimico Farmaceutico|June 1, 1993
Pharmacokinetics/pharmacodynamics during phase II and III studies: population kinetics and the kinetic screenL P Balant, M Gex-Fabry
Pageof 7